Mexico – A researcher at Mexico's Autonomous Metropolitan University (UAM) has designed a low-cost device for neurotherapy or brain studies that will greatly reduce sequelae in patients, the institution said in a statement today.
Carlos Angulo Álvarez, professor-researcher at the Department of Processes and Techniques at the UAM Azcaptozalco, explained that this responds to the fact that currently studies and brain therapies "are invasive procedures and not at all comfortable."
This, according to him, is due to the use of wired interfaces or means connected to systems to process information through electric brain currents for its implementation.
One of these therapies is "neurofeedback," a neurobehavioral treatment that allows for self-control in certain patterns of brain activity and in the pursuits of everyday life, he said.
He noted that in addition, "the devices with which brain analyzes are performed are costly."
This, he continued, limits the possibilities of constant neurotherapy to contribute to neuronal re-education after a stroke and / or to improve attention-deficit / hyperactivity disorder.
Therefore, Angulo μlvarez developed a wireless device that would help perform this type of neurotherapies, which can be used in studies and diagnoses for these problems.
With this instrument, people can perform the therapies from the comfort of their homes through mobile devices and through the available applications to send them to the neurologist in order to analyze them in each session or brain study.
Among the goals of the research are to reduce artifact costs according to demand, harness available technology and resources, and generate a social benefit for patients who survive this type of health problem.
The researcher, who studies the PhD in Design at UAM, indicated that the generation of a low cost object that involves less time in the placement and removal will contribute to a less invasive process, reducing the patient's discomfort.
It will also generate a motivation to practice these procedures more consistently, "based on the assumption that a higher incidence will stimulate neuronal re-education and the prognosis of rehabilitation will be between 85 and 90%," he concluded.